company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2953000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2953000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1047900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1146700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5154500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5154500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1082400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2784200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1127600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,32300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,800100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-166300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4328100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4328100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1528000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1853600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2536700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-844900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-844900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,129700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2007.0,FY,2007-01-01,2007-12-31,2010-02-22 12:45:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,111200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2071900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2071900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1122600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6878100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1366800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7295600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7295600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-947200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6205000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2412400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2554900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-284800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7268800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7268800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-657900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2056700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5060600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2346000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2346000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-96600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,FY,2008-01-01,2008-12-31,2010-02-22 12:45:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2276200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3629400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3629400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,280300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4774800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,954800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2380500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2380500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-275700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6038600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-879700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1901400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-199400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5466300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5466300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-248100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-515200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5060500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4297200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4297200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-68300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q4,2008-10-01,2008-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1143100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1557500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1557500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,842300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2103300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,412000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4915100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4915100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-671500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-166400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1532700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,653500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-85400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1802500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1802500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-409800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1541500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1951200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1951200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-28300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-10-30 13:15:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1133100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,915400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,915400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,375800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2593600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1866200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2018600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2018600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-256800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-90000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,17700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,201500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-23700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-254300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-254300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-594800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-539700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1128500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1128500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-21100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,614700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4328800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4328800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1297800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-886600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-404500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4335500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4335500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-765000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-90000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-432300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,17700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1506900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-94500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,142800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,142800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5824200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2152100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2442600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5533700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5533700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,21600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,FY,2009-01-01,2009-12-31,2012-02-24 17:07:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1033800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-216000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-216000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1202300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1294600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2416500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4697400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4697400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-783900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6038600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1209000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3206800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-270200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5069200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5069200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5477500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2127600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7497100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-108000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-108000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-25600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3TTM,2008-10-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-505400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,941800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,941800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,363900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1305700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1305700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,67700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-913200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,65700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,525900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1158500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1158500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-235200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,923300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,923300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,102100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1111600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,95400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q2,2009-04-01,2009-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1313100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1313100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,306300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-988600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-542900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,87900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,87900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-157000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,471000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-19000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,227300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,227300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4243600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-536800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2400000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2380400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2380400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-118400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2009.0,Q1,2009-01-01,2009-03-31,2010-04-30 10:09:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2183600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1169600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1169600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,338500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,183900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,536100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2228100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2228100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-250900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-354100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1034900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,24600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,140300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-89500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1564500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1564500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-544100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-5100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-549600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-549600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,84400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5069500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5069500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1328200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,263500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,195600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6856800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6856800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-694300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1101800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1753700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,24600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,584700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-219300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3159800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3159800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2165300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,144500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2021900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2021900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-144800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,FY,2010-01-01,2010-12-31,2013-02-21 10:28:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1530300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4815300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4815300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1365500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2673200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2206700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6647300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6647300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-700200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-837700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-821800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,17700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,645900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-153500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1849600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1849600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-595500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2160900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,155600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2600800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2600800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-136300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2060600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1302900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1302900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,344700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,65700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,45800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1759100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1759100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-164100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-199300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-464000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,61400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-22500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-788500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-788500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,2600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-545300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,148900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-393800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-393800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,168500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,745300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4454200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4454200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1739700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6193900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6193900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-993400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3120200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-239100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1841200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1348900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1348900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,345600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-35800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,252900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1911600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1911600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-154200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-498400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-196800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,192000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-96800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-754200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-754200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,4600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-536700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-531500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-531500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-187600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,438300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4263800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4263800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1290900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,151700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-500800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5205600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5205600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-733100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-140000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-422600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,17700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1226900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-86000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-137100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-137100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1588500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2154500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,42700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3700300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3700300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,43900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1412100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1248100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1248100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,299400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-639200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,958000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,958000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-125100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,191000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-52600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-52600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-539200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-547000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-547000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-96100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 12:57:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,262300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,858200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,858200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,318900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,37200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,730400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1944700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1944700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-255900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-415200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3858900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2318800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,309100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1876800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1876800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-112600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-543900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-650900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-650900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-92200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-675200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4347700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4347700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1373600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,551100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,962100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7234500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7234500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-672000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1328700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6683200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3946400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-112200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4824400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4824400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-195800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2180100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2369900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2369900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-110900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,FY,2011-01-01,2011-12-31,2014-02-19 13:34:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-70700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3489500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3489500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1054700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,513900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,231700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5289800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5289800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-416100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-913500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2824300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1627600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-421300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2947600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2947600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-83200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1636200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1719000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1719000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-18700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3YTD,2011-01-01,2011-09-30,2011-10-28 15:35:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,604500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4659100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4659100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1393200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,697800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,767800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7517900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7517900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-667000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1267600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3859200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,24600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1767900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-510800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4512100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4512100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-83600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2180300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-4700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2268600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2268600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-48300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,688900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1236300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1236300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,358200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,187500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,291400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2073400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2073400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-175700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-480700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1023200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,673200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1008300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1008300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,99900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-540900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-440900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-440900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-140000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,484200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2253200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2253200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,696500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,326400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-59700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3216400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3216400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-240400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-432800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1801100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,954400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-419400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1939300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1939300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-183100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1095300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1278100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1278100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,121300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2YTD,2011-01-01,2011-06-30,2011-07-29 15:48:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,120300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4725700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4725700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1379700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,576000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,522200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7203600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7203600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-655400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-986200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3300000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,24600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1156100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-531400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4292300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4292300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-180900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2184700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,144100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2221500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2221500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,260200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,950000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1197300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1197300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,355600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,36300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,451100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2040300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2040300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-139000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-403200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1562800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,203500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1898600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1898600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-552100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-564300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-564300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,29700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-392900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1055900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1055900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,340900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,290100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-510800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1176100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1176100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-101400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-29600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-238300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,750900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-422300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-170800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-543200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-713800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-713800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,91600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1,2011-01-01,2011-03-31,2011-04-29 12:57:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,513200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4877300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4877300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1369700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,503900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,324000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7074900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7074900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-670600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1081400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1934000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,24600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1144600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-631100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3147900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3147900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-164000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2169300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,144600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2188700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2188700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,42900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1781200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,827300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,827300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,344600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,163300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,266800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1602000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1602000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-413200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-36800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4284200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,22000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2923500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,126200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1662500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1662500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,4100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-721100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-548200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1265200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1265200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1300400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4088600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4088600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1462200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-508200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,262200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5304800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5304800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-905400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-338100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9791000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,22000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1212100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6903200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,64400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2832800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2832800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1511100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-721100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2187400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4419600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4419600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,43900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 16:02:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1903700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3261300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3261300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1117600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-671500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3702800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3702800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-492200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-301300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5506800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1212100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3979700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-61800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1170300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1170300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1515200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1639200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3154400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3154400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3YTD,2012-01-01,2012-09-30,2012-10-26 15:24:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-603300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4119500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4119500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1436500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-634300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,725800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5647500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5647500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-748100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-716500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9365700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1212100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6298500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,247300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3047100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3047100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1627800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2183100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3805300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3805300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-73600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1278500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1326600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1326600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,369700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-737300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,585300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1544300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1544300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-182000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-102000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2030200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1212100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,919700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,49700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-132700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-132700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-544200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-544700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-544700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,106500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,973400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1934700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1934700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,747900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,65800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-589900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2158500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2158500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-310200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-199300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3476600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3060000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-111500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1037600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1037600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1514700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1095000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2609700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2609700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-87900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2YTD,2012-01-01,2012-06-30,2012-07-27 13:05:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1576700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4029200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4029200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1425000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,290500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,431900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6176600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6176600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-741800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1095200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8358700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6052000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,195700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3922700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3922700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1527400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2179800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3701500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3701500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-320100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1767700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,923600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,923600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,362000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,37600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1306000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1306000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-179500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1320500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1179200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-60600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-385300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-385300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-550400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-552700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-552700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-144400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,223600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1011100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1011100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,385900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-572700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,852500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,852500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-130700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-195400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2156100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1880800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-50900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-652300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-652300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1512400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-544600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2057000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2057000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,56500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1,2012-01-01,2012-03-31,2012-04-30 15:25:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1800300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4302900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4302900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1418600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,289200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,900200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6910900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6910900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-701300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1494500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8601000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5076300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,259200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5436000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5436000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1537400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2181500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3713100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3713100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-146000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2384200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,727500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,727500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,351200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,35900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,612200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1726800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1726800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-464000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-81200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4554800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,179400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3694100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1232400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1232400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-500000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-528900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1036400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1036400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-538700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4684800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4684800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1445600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-354400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-41000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5735000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5735000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1012100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-124900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15572900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,179400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14555100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-97400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2072800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2072800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1698100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2120700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3829300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3829300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-21500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,FY,2013-01-01,2013-12-31,2015-02-19 16:02:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-188600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3957300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3957300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1094400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-390300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-653200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4008200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4008200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-548100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-43700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11018100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10861000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-91500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-840400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-840400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1198100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1591800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2792900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2792900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-24800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3YTD,2013-01-01,2013-09-30,2013-10-30 11:21:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,350100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4784600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4784600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1439000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-227000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-386400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5610200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5610200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-961300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15302300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,22000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13784500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,34700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2502900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2502900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1919200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2140000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4058100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4058100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-950300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1203100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1203100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,349000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,36300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,403200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1991600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1991600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-253800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-43700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4026400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3415900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-35800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-943800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-943800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-527700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-529000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-529000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,63600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,582400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2754200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2754200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,745400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-426600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1056400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2016600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2016600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-294300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6991700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7445100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-55700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,103400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,103400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1198100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1064100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2263900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2263900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-88400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2YTD,2013-01-01,2013-06-30,2013-07-26 11:57:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-232300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4908100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4908100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1459700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1000600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-204300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5162900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5162900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-889500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-138800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13306100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,22000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1212100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11288300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,120200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1691800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1691800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1919200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2156500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4073800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4073800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,43400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-559300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1206200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1206200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,363900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,33600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1637200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1637200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-136400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4817200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3739200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-37300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1251700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1251700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-533000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-533800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-533800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-150100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1548000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1548000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,381500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-460200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1089900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,379400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,379400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-157900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2174500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3705900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-18400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1355100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1355100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1198100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-531100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1730100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1730100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-86600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1,2013-01-01,2013-03-31,2013-04-26 11:42:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-82200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4625500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4625500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1457800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-996600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-255000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4831700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4831700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-932600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-142700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9809400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,22000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1212100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8728300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,96900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-825400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-825400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1919200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2173900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4092700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4092700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-99200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-185600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2390500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2390500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1379000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,696900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4458400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4458400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1162600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-954700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11440500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,15300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15063500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5430100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3909100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3909100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1034800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-800000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2101200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3769600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-166400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-166400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-341500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 15:32:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,428500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,428500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,339400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,234000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,439000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1440900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1440900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-408800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-358300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1402000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,15300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5046400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5071500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2178900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2178900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-525200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2362800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1537100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1537100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-93300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,705800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1962000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1962000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1039600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,462900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-447000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3017500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3017500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-753800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-596400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10038500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10017100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-358600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1730200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1730200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1034300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-500000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1576000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1406800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1703500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1703500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-248200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 15:07:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-664400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2689500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2689500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1390800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,498800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,165200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4744300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4744300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1217800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-677600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14593300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,179400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13711200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-364500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2962600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2962600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1041800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2104900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1406800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2739900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2739900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-244900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1203100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,500600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,500600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,342400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,392900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,455400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1691300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1691300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-296900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-45000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3639300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2587300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-255800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1649700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1649700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,7500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-525000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,411600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-405900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-405900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-235600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-599900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3392000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3392000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1397400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,142200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,113000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5044600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5044600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1174700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-676300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14980400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,179400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14539800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-144500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2256700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2256700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1050600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-700000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2107600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,995200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2863000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2863000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,54300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,733500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,733500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,348400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-59700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1053900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1053900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-254900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-526400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3226200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3629500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-90900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-468900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-468900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-32900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-145000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-526900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-702500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-702500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-122300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1461400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1461400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,697200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,70000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-902400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1326200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1326200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-456900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-551400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6399200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7429800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-102800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1041800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1051000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,995200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1297600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1297600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-30 16:17:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-64500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,727900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,727900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,348800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,38300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-842700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,272300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,272300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-202000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3173000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3800300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-11900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,388400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,388400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1008900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-55000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-524100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,992900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-595100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-595100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1,2014-01-01,2014-03-31,2014-04-28 14:28:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3864700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3864700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1412900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,144100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,206200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5627900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5627900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1056200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-149900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16571400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,179400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14649500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-90900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3039500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3039500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1018500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-555000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2113700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,992900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2694300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2694300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,57300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2408400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2408400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1427700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,752800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1624300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2964600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2964600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1066200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5843100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4068700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,502600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5230200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5272000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4688900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-749500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2127300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4454700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3111000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3111000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-85600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,FY,2015-01-01,2015-12-31,2018-02-20 17:27:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-205200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,478400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,478400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,343400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,443500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-269200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,996100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,996100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-380200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-169300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-631100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,92600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1372600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-30900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,253700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,253700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-57600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-252900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-533300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-27600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-871400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-871400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,49200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,427600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1930000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1930000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1084300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,309300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1355100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1968500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1968500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-686000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5673800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3437600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,410000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3857600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5302900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-226900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-226900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4631300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-496600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1594000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4482300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2239600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2239600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-134800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-28 12:02:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-632800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2358500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2358500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1423700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,543300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-916100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3409400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3409400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1094800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6032100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4839600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,425300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8904000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,231400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2405800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2405800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4631800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-796600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2119200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6845100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-702500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-702500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-228100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,73000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,799700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,799700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,358300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,54700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-108000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1104700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1104700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-273500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-61100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1016300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,821800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-41000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-570100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-570100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-61100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-526300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-5000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-594400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-595200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-16100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-76700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1130300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1130300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,726000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,254600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1247100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,863800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,863800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-412500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5612700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2421300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,410000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3035800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5343900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,343200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,343200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4629300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-435500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1067700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4487300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1645200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1644400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-118700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 13:00:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-556100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2059400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2059400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1407800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,881500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-352700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3996000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3996000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1118200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6016000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7462600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,425300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10669500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,16600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3485400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3485400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4622300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1035500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2117900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7261700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-514000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-513200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-447600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-450200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,600800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,600800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,368500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,156000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-176700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,948600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,948600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-223900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-136000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1331100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1932400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-59000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,182400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,182400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2540700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-124900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-539800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2261400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-944000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-943200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,62900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,250700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,529500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,529500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,357500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,98600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1070400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-84800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-84800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-188600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5476700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1090200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,410000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1103400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5402900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,160800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,160800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2088600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-310600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-527900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2225900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-701200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-701200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-181600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 13:26:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-806800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2192100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2192100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1387700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,757200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-235700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4101300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4101300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1149200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6406400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9357700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,425300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12366600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-15300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4136700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4136700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2114500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1055600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2105000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5002600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-272500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-272500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-515300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-823200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2737600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2737600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1496600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,285300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,331500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4851000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4851000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1037000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-100000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5673400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,73400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3728000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-130100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3139100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3139100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-301000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-600100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2158500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2499800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-559800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-559800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-236400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,FY,2016-01-01,2016-12-31,2019-02-19 10:41:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,915700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,771800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,771800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,344600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,96800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,793300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2006500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2006500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-409800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-55000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1607000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,73400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,875300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-55000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1178100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1178100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-66900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-541100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1293200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,385200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,385200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-120500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1093100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1965800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1965800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1152000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,188500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-461800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2844500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2844500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-627200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-45000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4066400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2852700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-75100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1961000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1961000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-234100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1617400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1206600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-945000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-945000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-115900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 11:53:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-177400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2444200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2444200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1495400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,632000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-731000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3840600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3840600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1007400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-214300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4697500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,92600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4225300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-106000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1707300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1707300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-291700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-553000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2150700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1179000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1816400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1816400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-66700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,250200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,778000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,778000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,392800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,61500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,429400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1661700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1661700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-227500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1531900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1008000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-43300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-794700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-794700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-62200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-537900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-600100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-600100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-15900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,251000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1187800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1187800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,759200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,127000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-891200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1182800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1182800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-399700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-45000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2534500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1844700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-31800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1166300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1166300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-171900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1079500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1206600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-344900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-344900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-100000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 11:42:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-428400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2465900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2465900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1460900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,625200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1268400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3283600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3283600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1053400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-275400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4181900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,92600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4039100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-103700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1482700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1482700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-231500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-614100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2139100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1174000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1810700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1811500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-66900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-77500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,747700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,747700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,373700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,65000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,215500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1401900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1401900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-245400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-45000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1719400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,984200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1020900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1020900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-86100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-541200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1206600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,579300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,579300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-29900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,930400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,440100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,440100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,385500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,62000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1106700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-219100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-219100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-154300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-815100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,860500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-36500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-145400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-145400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-85800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-538300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-924200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-924200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-70100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 11:49:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1358800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2319000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2319000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1455700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,716200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1660600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2830300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2830300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1031900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-366400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3793600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,92600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4987300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-167400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-279400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-279400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2686100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-739000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2137700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2228800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3334000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3334000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,25900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-757200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-204100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-204100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1567300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1393900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2858500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5615600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5615600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1076800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1968900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8001300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7438500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-175100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3783600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3783600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-995000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-299800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2192100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3629500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,142600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,142600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-20500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,FY,2017-01-01,2017-12-31,2020-02-19 12:33:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1954100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1656900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1656900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,411900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,122200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2866300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1743500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1743500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-443500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1287900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3431400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1652900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1652900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-64800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-99900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-548300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,170700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-542300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-542300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-42200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2811900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1452800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1452800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1155400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1271700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3872100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3872100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-633300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1918900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6713400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4007100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-178000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5436500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5436500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-930200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-199900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1643800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3458800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,684900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,684900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,21700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 10:35:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-857800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2224600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2224600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1500000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1368500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,785500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5878600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5878600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1043100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1973900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8320400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,73400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4882400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-233000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6614600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6614600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-997100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-499900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2184900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4752000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1070100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1070100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-98800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,235300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,555600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,555600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,372900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,274900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,677700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1881100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1881100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-242700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-205000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2471100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1221900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-61100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1758000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1758000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-52700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-547700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1101100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,500700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,500700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,30600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,654400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,897200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,897200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,782500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,996800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-685500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1991000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1991000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-390600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1713900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4242300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2785200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-116900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3678500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3678500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-877500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-199900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1096100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2357700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,184200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,184200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-25 16:48:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1512200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2447000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2447000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1519900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1155100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,537200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5659200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5659200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1027900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1768900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7381200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,73400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4668500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-215200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5651300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5651300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1006600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-499900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2175100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3650900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-30700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-30700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-145300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-168100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1008000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1008000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,395600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,69900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,177600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1651100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1651100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-221600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3007000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1088800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-109100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2248900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2248900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-51700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-199900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-548700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1860200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1059900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1059900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,453000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-110800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-110800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,386900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,926900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-863100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,339900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,339900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1713900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1235300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1696400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1429600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1429600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-825800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-547400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,497500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-875700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-875700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 11:32:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1965200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2186700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2186700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1498000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1150200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,575100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5410000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5410000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1051700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1813900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6093600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,73400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4563900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-101400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4423300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4423300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1041000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2167600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2997300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-511300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-511300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-166100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,309300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3232000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3232000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1609000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2263400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1579900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5524500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5524500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1210600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1807600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-950100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6062000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-187700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1906000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1906000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3579800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4150700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2311800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2477700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5904900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5904900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-63600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,FY,2018-01-01,2018-12-31,2020-02-19 12:33:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1462000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1125000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1125000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,345500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,406700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-424000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1453200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1448700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-394300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-229400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-118200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-659000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-659000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,32900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1100000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-572600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1639700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1639700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-111800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-961800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2107000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2107000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1263500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1856700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1155900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4071300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4075800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-816300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1578200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-831900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5980200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-188800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2565000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2565000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3612700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3050700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1739200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2477700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4265200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4265200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,48200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 11:54:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2423800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,450100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,450100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1675400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1978900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1710400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5814800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5819300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1259800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1628200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2119800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9411600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-185900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4217900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4217900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3677500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3150600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2287500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2648400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4807500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4807500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5235700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1149500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1149500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,415500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,94000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,458300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2117300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2121800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-269800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-30000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,88400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-143500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-398100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-398100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2132100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-572600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2477700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,432700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,432700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-13700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2142700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,957500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,957500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,848000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1762700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1614200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1954000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1954000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-546500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1548200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-788700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5891800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-45300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2963100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2963100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1480600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2050700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1166600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4697900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4697900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,61900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-02 12:47:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,281100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-143800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-143800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1632800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2159800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1929800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5578600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5578600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1232700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1803200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4547700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10545100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-103500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2858000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2858000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1598100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2150600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2262600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1271800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4739500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4739500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,50300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3747400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-259900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-259900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,425200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1694700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-342500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1517500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1517500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-310000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1548200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-114900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5130600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-24100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3133400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3133400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,698600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-950700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-579300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-831400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-831400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-86500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3733000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1217400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1217400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,422800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,68000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1271700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,436500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,436500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-236500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-673800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,761200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-21200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-170300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-170300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2179200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1100000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-587300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3866500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3866500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,148400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 14:09:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3451900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1124100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1124100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1603200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,535000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2449900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5712200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5712200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1144300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-255000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7439800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6503300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-188500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2524300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2524300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2348400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1399800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2232000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3132000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2848200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2848200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,127700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,467400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1495700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1495700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,340700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-228200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,355500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1963700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1963700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-326500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-374000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,354800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,131700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,232000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-41400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2271000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-587200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2044600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1113600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1113600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-35000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,773700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8318400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8318400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1232600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3438300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1276100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4836600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4836600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1033900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7611300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-290200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,354800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,746400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-248700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8082900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8082900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3066500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4400000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2409800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7551800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2324500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2324500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-89900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,FY,2019-01-01,2019-12-31,2020-02-19 12:33:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5660700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7947700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7947700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1237400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2803400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2055600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4326100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4321600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1101700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7466700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-349000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,696500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-479600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8700500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8700500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-762600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5200000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2395200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5507200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2850600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2850600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-166700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7396200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1253900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1253900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,288000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,153200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-185000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1510100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1510100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-77700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,108900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-141500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-423800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-423800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-600000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-587400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-505400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1692900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1692900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-119800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-726400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6822700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6822700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,891900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3210100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1631600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2872900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2872900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-707400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7237300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-230800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,614700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-480700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8041500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8041500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-795500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4100000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1822600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5507200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1210900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1210900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-54900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 11:54:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6434400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7843300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7843300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1364900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2862600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1412300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4933300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4933300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1108100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7419000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-342100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,676000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-481600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8674800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8674800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2894600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5600000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2380400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8490300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-725000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-725000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-60600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4527100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1327200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1327200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,247400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,104500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-627600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1051500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1051500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-240300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-45000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-86400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,386300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,46400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,61000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,61000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-598000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-286100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-885800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-885800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,64900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,291600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5568800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5568800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,603900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3363300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1446600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1362800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1362800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-444000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7159600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-180700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,505800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-339200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7617700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7617700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-795400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3500000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1235200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6012600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,482000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,482000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,64900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-02 12:47:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5708000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4241600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4241600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,356500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3467800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-819000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,311300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,311300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-203700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7114600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-94300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,119500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-385600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7678700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7678700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-793700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3500000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-637200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6298700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1367800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1367800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 09:46:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5999600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6256200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6256200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1542700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1272400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1127200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5399300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5399300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1177800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8922200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-370600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5420300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-552100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5602400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5602400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2194300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6550700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2361700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8776400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1659700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-670600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-670600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-212000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1085700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5533300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5533300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1149700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,153600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1928900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4907700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4907700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1088500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1359000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-278900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,354800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,718200000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,188300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1465100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1465100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2743500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1400000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2443900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3001800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3585600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3585600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-89900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-232900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1456500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1456500000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,273600000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,124100000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1471800000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,382400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,382400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-258300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-862300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-83000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,51400000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1060900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1060900000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-470700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-500000000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-671300000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1748700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,106700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,106700000.0
Eli Lilly and Co,LLY,FRDRIPF3EKNDJ2CQJL29,0000059478,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 09:46:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-571800000.0
